Consultancy works with clients ranging from start-up biotechs to large pharmaceutical companies, providing strategic consulting on payer requirements through the development process from POC through Phase III and registration. • Lead strategic development of robust payer plans to support commercialization and launch phase including pricing/contracting strategies and tools to support reimbursement submissions for key global markets including the U.S. market • Built, refined, and executed processes across business/financial planning, business development, marketing, managed care contracting, and launch excellence process maps and tools. • Provide strategic guidance on asset acquisition and valuation including commercial viability, pricing and access opportunities and value demonstration • Serve as a broadly leveraged expert due to vast experience working on small molecules, biopharmaceuticals and vaccines in primary and specialty care settings in many therapeutic areas including Women's Health, Neuroscience, Infectious Disease, Rheumatology, Oncology, Respiratory, Cardiovascular and Metabolic Disease and others. Proven track record of success building powerful brands,